1. Home
  2. DBRG vs HAE Comparison

DBRG vs HAE Comparison

Compare DBRG & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DigitalBridge Group Inc.

DBRG

DigitalBridge Group Inc.

N/A

Current Price

$15.77

Market Cap

2.9B

Sector

Real Estate

ML Signal

N/A

Logo Haemonetics Corporation

HAE

Haemonetics Corporation

N/A

Current Price

$75.24

Market Cap

2.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DBRG
HAE
Founded
1991
1971
Country
United States
United States
Employees
311
N/A
Industry
Real Estate Investment Trusts
Medical/Dental Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
2.8B
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
DBRG
HAE
Price
$15.77
$75.24
Analyst Decision
Hold
Buy
Analyst Count
8
9
Target Price
$16.00
$84.13
AVG Volume (30 Days)
2.9M
972.3K
Earning Date
05-12-2026
05-07-2026
Dividend Yield
0.26%
N/A
EPS Growth
N/A
N/A
EPS
N/A
2.05
Revenue
N/A
$910,373,000.00
Revenue This Year
$373.39
N/A
Revenue Next Year
$8.23
$5.23
P/E Ratio
$252.25
$36.53
Revenue Growth
N/A
N/A
52 Week Low
$8.94
$47.32
52 Week High
$15.82
$87.32

Technical Indicators

Market Signals
Indicator
DBRG
HAE
Relative Strength Index (RSI) 56.35 54.75
Support Level $15.33 $72.04
Resistance Level $15.82 $80.90
Average True Range (ATR) 0.05 2.53
MACD -0.00 -0.65
Stochastic Oscillator 54.17 25.19

Price Performance

Historical Comparison
DBRG
HAE

About DBRG DigitalBridge Group Inc.

DigitalBridge Group Inc is a developer of alternative asset manager dedicated to investing in digital infrastructure. The company's platform invests in and operates businesses across the digital ecosystem, including cell towers, data centres, fiber, small cells, and edge infrastructure, to provide clients with funds for digital infrastructure real estate infrastructure.

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Share on Social Networks: